Cape Biologix focuses on developing advanced biotechnological solutions aimed at improving health outcomes. The company specializes in the creation of innovative biologics, which are products derived from living organisms. Their pipeline includes a range of therapeutic candidates designed to address various medical conditions, leveraging cutting-edge techniques in molecular biology and biochemistry. By utilizing these technologies, Cape Biologix aims to enhance the efficacy and safety of treatments, ultimately contributing to the advancement of personalized medicine.

In addition to their product development, Cape Biologix emphasizes the importance of rigorous scientific research and validation. The company employs state-of-the-art methodologies in their research processes, including high-throughput screening and advanced analytics, to ensure the reliability and effectiveness of their biologics. Their commitment to scientific excellence is reflected in their collaborative efforts with academic institutions and industry partners, fostering an environment of innovation and discovery that drives the development of next-generation therapies.

South Africa

Cape Biologix Technologies develops and manufactures plant-made,  recombinant monoclonal proteins.

We use our plants as single-use, biodegradable bioreactors to produce pharmaceutically relevant proteins for multiple uses across diagnostics, vaccines, or therapeutic applications. 

As you might have noticed, we LOVE plants. We love them so much in fact that we're on a mission to use plant biotechnology to improve the well-being of people, animals, and plants 💚 

Feel free to reach out to us if you're like to connect.

Cape Biologix

Company Details